Clinical Trials Browser

Phase 1/2 × Terminated × Smoldering Multiple Myeloma × Clear all

NCT02353572 2015-03-09

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1/2 Terminated

3 enrolled 5 charts

Smoldering Multiple Myeloma, Multiple Myeloma